Pay in 4 interest-free payments of $6.03 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Research institutions benefit from this guarantee structure as it provides flexibility for experimental planning and budget management
Search registered cagrilintide and tirzepatide studies at ClinicalTrials.gov
No IGF-1 or Growth Hormone Receptor Activation Full-length growth hormone produces complex metabolic effects including appetite stimulation through IGF-1 (insulin-like growth factor-1) production and direct growth hormone receptor activation
Research Highlights Metabolic Regulation and Anti-Obesity Effects: Potent inhibition of nicotinamide N-methyltransferase (NNMT) increases cellular NAD and S-adenosylmethionine (SAM) levels, enhances polyamine flux, boosts energy expenditure, and suppresses lipogenesis
When Tesamorelin binds with the GHRH receptor in the pituitary glands, it stimulates the release of the growth hormone that sends signals to the liver to produce insulin-like growth factor-1 (IGF-1)
